Advertisement · 728 × 90
#
Hashtag
#VSEE
Advertisement · 728 × 90
Preview
VSee Unveils World's First Autonomous Telehealth AI Robot at HIMSS 2026 VSee (NASDAQ:VSEE) unveiled the VSee AI Robot at HIMSS 2026, a fully autonomous telehealth robot that navigates to patient bedsides without staff escort, using LiDAR and 30X optical/infrared night vision. Key capabilities include virtual rounding, telestroke response, programmable medication delivery, and integration via the no-code VSee AI Workflow Engine. The company cites platform scale: 1.5M video encounters/month and capacity for 1,800+ appointments/day, and promises customization timelines of 1 day to 1 month.

#VSEE VSee Unveils World's First Autonomous Telehealth AI Robot at HIMSS 2026

www.stocktitan.net/news/VSEE/v-see-unveils-...

0 0 0 0

I am a proud stealer of all TV!!! #VSee

2 0 1 0
Preview
VSee Launches AI-Driven Rural Health Transformation Platform, Targeting Millions in Recaptured Revenue Per Hospital VSee's Rapidly Configurable AI Telehealth Platform Addresses Rural Hospital Access and Financial SustainabilitySAN JOSE, CALIFORNIA / ACCESS Newswire / January 12, 2026 / VSee Health, Inc. (Nasdaq:VSEE) today announced the launch of its AI‑enhanced Rural Health Transformation Solution, a modular

#VSEE VSee Launches AI-Driven Rural Health Transformation Platform, Targeting Millions in Recaptured Revenue Per Hospital

www.stocktitan.net/news/VSEE/v-see-launches...

0 0 0 0
Preview
VSee Health, Inc. Announces Pricing of $6.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor VSee Health (NASDAQ:VSEE) announced a private placement with a single institutional investor to raise approximately $6.0 million in gross proceeds. The financing consists of 9,836,065 shares (or equivalents) and warrants to purchase up to 19,672,130 shares at a combined effective price of $0.61 per share.The warrants carry a $0.61 exercise price, are exercisable following shareholder approval, and expire five years from initial exercise. Closing is expected on or about December 1, 2025. The company plans to use net proceeds for working capital and general corporate purposes and engaged A.G.P./Alliance Global Partners as sole placement agent.The company will file a resale registration statement within 20 calendar days of closing and aims to have it declared effective within 60 days.

#VSEE VSee Health, Inc. Announces Pricing of $6.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor

www.stocktitan.net/news/VSEE/v-see-health-i...

0 0 0 0
Preview
VSee Health's iDoc Division Powers Ahead: Delivering on Major Contracts and Igniting Revenue Growth! SAN JOSE, CALIFORNIA / ACCESS Newswire / November 25, 2025 / VSee Health, Inc. (NASDAQ:VSEE), a leader in innovative telemedicine solutions, today announced exciting progress in implementing and fulfilling its previously announced contracts through its iDoc platform. Unlike many public companies

#VSEE VSee Health's iDoc Division Powers Ahead: Delivering on Major Contracts and Igniting Revenue Growth!

www.stocktitan.net/news/VSEE/v-see-health-s...

0 0 0 0
Preview
VSee Health Names Dr. Milton Chen as Chairman to Drive AI Infrastructure Growth Appointment strengthens execution as the company accelerates AI infrastructure growth.SAN JOSE, CA / ACCESS Newswire / November 20, 2025 / VSee Health, Inc. (Nasdaq:VSEE), today announced the appointment of Dr. Milton Chen as Chairman of the Board. Dr. Chen, the cofounder and CEO of VSee wrote the

#VSEE VSee Health Names Dr. Milton Chen as Chairman to Drive AI Infrastructure Growth

www.stocktitan.net/news/VSEE/v-see-health-n...

0 0 0 0
Preview
VSEE Health, Inc. Delivers Robust Q3 2025 Revenue Growth Amid Telehealth Expansion: Total Revenues Reach $3.98 Million, Up 19% Year-Over-Year VSEE Health (Nasdaq:VSEE) reported Q3 2025 total revenues of $3.98M, a 19% YoY increase, and YTD revenues of $10.69M, up 60% YoY. Gross margin remained ~52%. Telehealth fees rose 196% YoY to $1.44M and patient fees increased 42% to $0.88M. Cash used in operations improved to $1.52M for nine months (46% better YoY) while cash on hand was $472,759. Company cited full activation of a $10M+ teleradiology deal (100,000+ reads) and achieving FedRAMP High status. Balance sheet shows total assets of $18.71M and total current liabilities of $23.42M, with an accumulated deficit of $74.57M.

#VSEE VSEE Health, Inc. Delivers Robust Q3 2025 Revenue Growth Amid Telehealth Expansion: Total Revenues Reach $3.98 Million, Up 19% Year-Over-Year

www.stocktitan.net/news/VSEE/vsee-health-in...

0 0 0 0
Preview
VSee Health Pioneers Telehealth Expansion with FedRAMP Authorization and ICU Robot Integration, Fueling 2025 Growth Surge SAN JOSE, CALIFORNIA / ACCESS Newswire / November 11, 2025 / VSee Health, Inc. (Nasdaq:VSEE) a leader in HIPAA-compliant telemedicine solutions, leveraging its newly secured FedRAMP Moderate authorization to deliver secure, scalable telehealth services to federal agencies and beyond. In a bold step

#VSEE VSee Health Pioneers Telehealth Expansion with FedRAMP Authorization and ICU Robot Integration, Fueling 2025 Growth Surge

www.stocktitan.net/news/VSEE/v-see-health-p...

0 0 0 0

BREAKING NEWS: ( NASDAQ: #VSEE ) VSee Engages Philippine Health Leaders and Former VP Robredo in Southeast Asia expansion effort

0 0 0 0
Preview
VSee Engages Philippine Health Leaders and Former VP Robredo in Southeast Asia expansion effort VSee explores collaboration with Philippine Tuberculosis Society and former VP Leni Robredo to expand digital health innovation for Naga City starting with maternal health and primary careSAN JOSE, CALIFORNIA / ACCESS Newswire / November 6, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a leading provider

#VSEE VSee Engages Philippine Health Leaders and Former VP Robredo in Southeast Asia expansion effort

www.stocktitan.net/news/VSEE/v-see-engages-...

0 0 0 0
Preview
VSee Health Secures Three-Year Platform Services Agreement with the Region's Sole Level 1 Trauma Center and Academic Health System Volume-based contract with no revenue ceiling covers virtual urgent care and behavioral health across more than 100 facilities; services commence January 1, 2026.SAN JOSE, CALIFORNIA / ACCESS Newswire / November 4, 2025 / VSee Health, Inc. (NASDAQ:VSEE) has executed a three-year platform services

#VSEE VSee Health Secures Three-Year Platform Services Agreement with the Region's Sole Level 1 Trauma Center and Academic Health System

www.stocktitan.net/news/VSEE/v-see-health-s...

0 0 0 0

BREAKING NEWS: ( NASDAQ: #VSEE ) VSee Health Accelerates Teleradiology Domination

0 0 0 0

Breaking News: ( NASDAQ: #VSEE ) Vsee stock soars on FedRAMP news but 'immediate' dilution risk warrants selling

0 0 0 0
Awakari App

Vsee stock soars on FedRAMP news but ‘immediate’ dilution risk warrants selling Vsee Health Inc (NASDAQ: VSEE) more than doubled after receiving FedRAMP High Authority to Operate (ATO) from the...

#Health #& #pharma #North #America #Stock #Market #Tech #World #USA #VSEE

Origin | Interest | Match

0 0 0 0

News; ( NASDAQ: #VSEE ) VSee Awarded US Department of Health & Human Services FedRAMP High ATO

0 0 0 0
Preview
VSee Health Strengthens Balance Sheet With The Elimination of Debt VSee Health (NASDAQ:VSEE) announced record-setting revenue growth and the elimination of over $5 million in legacy SPAC debt on October 23, 2025. The company said this debt removal strengthens its balance sheet, bolsters creditor confidence, and helps ensure compliance with NASDAQ listing requirements. Management framed the move as positioning VSee Health for sustained long-term growth and noted shareholder support as a key factor in the milestone.

#VSEE VSee Health Strengthens Balance Sheet With The Elimination of Debt

www.stocktitan.net/news/VSEE/v-see-health-s...

0 0 0 0
Preview
VSee Health (Nasdaq:VSEE) Secures Game-Changing 10M+ Teleradiology Contract, Igniting Explosive Growth in Booming Telehealth Sector VSee Health (Nasdaq:VSEE) announced a multi-year teleradiology contract executed May 7, 2025, with service delivery beginning June 15, 2025, for a premier Level 1 hospital system.The deal is projected to generate approximately $10 million in gross revenue over the next two years, with provisions for an additional $5M+ in potential revenue, and is described as set to double annual recurring revenue. Revenue recognition has begun and will appear in the company's upcoming Q3 10-Q. The release lists a quoted share price of $0.479 and market cap of $8,123,227.67 as of October 20, 2025.

#VSEE VSee Health (Nasdaq:VSEE) Secures Game-Changing 10M+ Teleradiology Contract, Igniting Explosive Growth in Booming Telehealth Sector

www.stocktitan.net/news/VSEE/v-see-health-n...

0 0 0 0
Preview
VSee Health Announces Filing Second Quarter 2025 Results VSee Health (Nasdaq:VSEE) reported Second Quarter 2025 results for the three months ended June 30, 2025, with revenue of $3.4 million, up 98% year-over-year and a rise in gross profit margin from 45% to 47%. The company reported improved operating cash use in the first six months of 2025 at $765,094 versus $2,594,214 a year earlier. Cash flow from financing for H1 2025 was $746,040 compared with $3,597,841 in H1 2024, and investing cash use was minimal at $15,466.The company attributes strong revenue growth to the acquisition and integration of iDoc Telehealth, expanded customer relationships, and new services that improved margins, while noting integration challenges remain.

#VSEE VSee Health Announces Filing Second Quarter 2025 Results

www.stocktitan.net/news/VSEE/v-see-health-a...

0 0 0 0
Preview
Nasdaq Grants VSee Health Critical Listing Extension: Company Has Until December to Meet Requirements Telehealth provider VSee Health receives Nasdaq extension to file delayed Q1-Q2 2025 reports by Oct 15 and meet equity requirements by Dec 1, maintaining its market listing status.

#VSEE VSee Health Secures Nasdaq Approval for Continued Listing

www.stocktitan.net/news/VSEE/v-see-health-s...

0 0 0 0
Preview
VSee Health Teleradiology Expands to 25 Hospitals for an Estimated $3.0 Million Annualized Revenue VSee Health (Nasdaq:VSEE) announced significant expansion of its teleradiology services, having implemented 17 out of 25 planned hospital integrations by August 2025. The company secured contracts with a major vendor for 22 hospitals, with an additional 3 hospitals recently awarded, bringing the total expected annual recurring revenue (ARR) to approximately $3 million.Following a successful pilot of 3 hospitals in May 2025, VSee rapidly expanded to 17 hospitals within three months. The company's teleradiology platform offers real-time interpretation of medical imaging, 24/7 coverage, and seamless integration with existing hospital systems, enabling remote radiologist consultations and improved diagnostic efficiency.

#VSEE VSee Health Teleradiology Expands to 25 Hospitals for an Estimated $3.0 Million Annualized Revenue

www.stocktitan.net/news/VSEE/v-see-health-t...

0 0 0 0
Preview
🖥️IMSPARK: Seamless Digital Care for Every Kidney Patient🖥️ Social justice, Digital Equity, Poverty, Accessible Technology, Marginalized communities, Pacific, COFA, Veterans, Low-Income, Affordable housing

www.imagine-pacific.com/2025/07/imsp...

🖥️IMSPARK: Seamless Digital Care for Every Kidney Patient🖥️

#ConnectedCare, #DigitalHealth, #HealthEquity, #IMSPARK, #KidneyJustice, #OracleCerner, #PacificCare, #PacificInnovation, #VSee

0 0 0 0
Preview
NASDAQ Threatens VSee Health Delisting: Company Missing Two Critical Financial Reports Telehealth firm faces NASDAQ delisting over delayed 10-K and 10-Q filings. Appeal hearing requested with 15-day trading stay. See potential OTC transition details.

#VSEE VSee Health Appeals NASDAQ Staff Delisting Notice

www.stocktitan.net/news/VSEE/v-see-health-a...

0 0 0 0
Preview
VSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical Trial VSee Health has been selected to support a NIH-funded Phase 3 clinical trial studying stroke recovery telerehabilitation at UCLA. The trial involves 29 hospitals and 202 patients, evaluating a 6-week gamified home-based telerehab program to improve arm functionality in stroke survivors. The study aims to reduce costs related to transportation, caregiver burdens, and hospital readmissions. VSee's HIPAA-compliant platform will facilitate secure delivery of interventions in the $328M global stroke rehab market. The trial, beginning Q3 2025, represents a significant milestone after twelve years of development and builds on VSee's involvement in previous Phase 1 and 2 studies. Success could lead to Medicare and private payer reimbursement while opening opportunities for telerehabilitation in other neurological conditions.

#VSEE VSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical Trial

www.stocktitan.net/news/VSEE/v-see-powers-g...

0 0 0 0
Preview
VSee Health, Inc. Receives Nasdaq Notice on Delayed Form 10-Q Filing VSee Health (NASDAQ: VSEE) has received a notice from Nasdaq on May 23, 2025, regarding non-compliance with listing rule 5250(c)(1) due to delayed filing of its Q1 2025 Form 10-Q and FY2024 Form 10-K. The company has until June 24, 2025, to submit a compliance plan. If Nasdaq accepts the plan, VSee may receive up to 180 days (until October 13, 2025) to regain compliance. The notice does not immediately affect VSee's stock or warrant listing on the Nasdaq Capital Market. The company has stated its intention to take necessary steps to file the required documents and regain compliance as soon as possible.

#VSEE VSee Health, Inc. Receives Nasdaq Notice on Delayed Form 10-Q Filing

www.stocktitan.net/news/VSEE/v-see-health-i...

0 0 0 0
Preview
VSee Health, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K Filing VSee Health (NASDAQ: VSEE) has received a notice from Nasdaq on April 25, 2025, regarding its failure to file the Annual Report on Form 10-K for the year ended December 31, 2024. The company is now non-compliant with Nasdaq's listing rule 5250(c)(1), which requires timely filing of periodic financial reports. While this notice does not immediately affect VSee's stock listing or trading status, the company has until June 24, 2025 to submit a compliance plan to Nasdaq. If accepted, Nasdaq may extend the compliance deadline to October 13, 2025. VSee Health has stated its intention to take necessary steps to file the Form 10-K and regain compliance as soon as possible.

#VSEE VSee Health, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K Filing

www.stocktitan.net/news/VSEE/v-see-health-i...

0 0 0 0
Preview
AI Telehealth Leader VSee Lands Major Contracts Worth $9M, Serves NASA and McKesson VSee's AI-powered platform processes 1.5M monthly telehealth visits, serving NASA and HHS. Recent $9M in contracts showcase rapid market expansion. Full analysis inside.

#VSEE VSee Health Highlights: AI-Powered Telehealth Redefining the $787 Billion Digital Healthcare Market

www.stocktitan.net/news/VSEE/v-see-health-h...

0 0 0 0
Preview
VSee's Healthcare Empire Expands: $9M in New Contracts Power 1.5M Monthly Patient Encounters VSee lands major government deal and strategic partnerships, processing 1.5M+ monthly telehealth encounters. New contracts total $9M+ as healthcare adoption accelerates.

#VSEE VSee Issues Shareholder Letter Highlighting 2024 Achievements and Strong Growth Outlook for 2025

www.stocktitan.net/news/VSEE/v-see-issues-s...

0 0 0 0